[Ip-health] Covid: UK fighting patent-free Covid vaccine proposals - BBC Newsnight

Thiru Balasubramaniam thiru at keionline.org
Sat Mar 20 10:51:35 PDT 2021


BBC Newsnight  @BBCNewsnight
4h
#Newsnight has been leaked a @WHO document revealing high income countries,
including the UK, are fighting proposals designed to help developing
countries manufacture their own #Covid19 vaccines.

FULL REPORT ➡️ bbc.in/30WpGDA

https://www.youtube.com/watch?v=TH5R8TSMNj4


--

https://www.bbc.com/news/world-56465395

Covid: Rich states 'block' vaccine plans for developing nations

Coronavirus pandemic

IMany experts say equitable access to vaccines is essential for global
population immunity

Wealthy countries - including the UK - are blocking proposals to help
developing nations increase their vaccine manufacturing capabilities,
documents leaked to BBC Newsnight show.

Several poorer countries have asked the World Health Organization to help
them.

But richer nations are pushing back on provisions in international law that
would enable them to achieve this.

This is according to a leaked copy of the negotiating text of a WHO
resolution on the issue.

Among those richer nations are the UK, the US, as well as the European
Union.

"Where we could have language in there that would make it easier for
countries to produce more vaccines and more medicines within their country,
it would include initiatives that would finance and facilitate that. The UK
is on the opposite side of the argument of trying to remove those kinds of
progressive proposals from the text," says Diarmaid McDonald, from Just
Treatment, a patient group for fair access to medicines.

A spokesperson for the UK government says "a global pandemic requires a
global solution and the UK is leading from the front, driving forward
efforts to ensure equitable access around the world to Covid vaccines and
treatments".

The spokesperson says the UK is one of the largest donors to international
efforts to ensure over one billion doses of coronavirus vaccines get to
developing countries this year.

If and when governments should intervene to ensure affordable supplies of
medicines is a long-standing issue.

But the ability of different countries to source vaccines and drugs has
been highlighted by the pandemic.

media captionCovid vaccine safety: How does a vaccine get approved?

Many experts say equitable access to vaccines is essential to prevent cases
and deaths and to contribute to global population immunity.

But the global capacity for producing vaccines is about a third of what is
needed, says Ellen t'Hoen, an expert in medicines policy and intellectual
property law.

"These are vaccines that are produced in wealthy countries and are in
general kept by those wealthy countries.

"Developing nations are saying we need to have a share of the pie, not only
the share of the vaccines, but also the share of the right to produce these
vaccines," she adds.

To make a vaccine you not only need to have the right to produce the actual
substance they are composed of (which is protected by patents), you also
need to have the knowledge about how to make them because the technology
can be complex.

The WHO does not have the authority to sidestep patents - but it is trying
to bring countries together to find a way to bolster vaccine supplies.

The discussions include using provisions in international law to get around
patents and helping countries to have the technical ability to make them.

But the drug industry argues that eroding patents would hinder its ability
to invest in future treatments for Covid and other illnesses.

Earlier this month, representatives of the US drug industry wrote to US
President Joe Biden to share their concerns.

"Eliminating those protections would undermine the global response to the
pandemic," they wrote, including ongoing efforts to tackle new variants.

It would also create confusion that could potentially undermine public
confidence in vaccine safety, and create a barrier to information sharing,
the representatives said.

"Most importantly, eliminating protections would not speed up production,"
they added.

Others agree. Anne Moore, an expert in vaccine immunology, worries about
what impact undermining patents will have on future research.

"Over time we see fewer and fewer organisations and commercial companies
being in the vaccine field because there's so little return on it," she
says.

Drug companies point out they have also donated financially and given
medicines to help tackle the pandemic.

But campaigners argue that about £90bn ($125bn) of public money has gone
into developing Covid treatments and vaccines so the public should have a
stake. Once the pandemic ends, there is a lot of money to be made, they say.

"It's obvious that there are longer-term plans to increase the price of
these vaccines once the most urgent phase of the pandemic is over. So that
is another reason why developing countries are saying we need to gain the
ability to produce these vaccines ourselves now," Ms t'Hoen says.

-- 
Thiru Balasubramaniam
Geneva Representative
Knowledge Ecology International
41 22 791 6727
thiru at keionline.org


More information about the Ip-health mailing list